Boston Scientific Corporation vs Rent the Runway Inc — how do they compare? Boston Scientific Corporation trades at $51.35 (market cap $74.19B), while Rent the Runway Inc trades at $3.64 (market cap $122.65M). The key difference: Boston Scientific Corporation is far larger — about 604.9× Rent the Runway Inc's market cap. Which is the better fit depends on your goals.
| BSX | RENT | |
|---|---|---|
Market Cap | $74.19B | $122.65M |
Sector | Health | Consumer Cyclical |
52-Week High | $108.14 | $9.39 |
52-Week Low | $42.63 | $3.01 |
Enterprise Value | $86.27B | $282.75M |
Signals from Pluang's Aura AI — not financial advice
Boston Scientific (BSX) trades at $51.27, up 1.6% with strong technical momentum and bullish moving averages. The company delivered three consecutive quarterly EPS beats in 2026, with Q2 EPS of $0.86 exceeding expectations. Revenue grew to $20.07B in 2025 with a 14.4% net margin, while analyst consensus shows 86% buy ratings with a $67.21 price target. Recent insider buying by the CEO and director signals confidence despite near-term guidance challenges.
BSX presents attractive valuation with 44% upside to consensus target, supported by strong fundamentals and institutional support. Key risks include competitive pressures in WATCHMAN and electrophysiology segments, along with elevated RSI levels suggesting potential near-term consolidation. The long-term growth trajectory remains intact with 2026 revenue projected at $21B and 17.5% margins.
RENT trades at $3.64, down 1.09% on the day, with a bullish technical signal from moving averages. The company reported Q1 2026 revenue growth of 29.2% year-over-year to $89.9 million, beating expectations, but net losses persist. Analyst sentiment is mixed with 42% buy ratings, while cash flow remains negative and debt levels are elevated.
The outlook hinges on execution under new leadership to achieve profitability. Investment opportunity lies in low valuation multiples if subscriber growth accelerates, but risks include high leverage and sustained cash burn. Wall Street consensus leans cautious despite recent earnings beats.
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →